Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the relative bioavailability of the test
formulation of Ondansetron HCl with the already marketed reference formulation Zofran® ODT
under non-fasting conditions in healthy, non-smoking, adult subjects.